Literature DB >> 8939064

Obesity genes and the regulation of body fat content.

D S Weigle1, J L Kuijper.   

Abstract

Physiological investigation has demonstrated that the central nervous system monitors body composition and adjusts energy intake and expenditure to stabilize total adipose tissue mass. Genetic variations in the signalling molecules involved in this regulatory system account for the heritable component of body fat content. The application of molecular techniques to rodent models of Mendelian obesity has resulted in the characterization of five loci at which mutations produce an abnormal accumulation of body fat. The genes at these loci include agouti, which encodes a molecule that antagonizes the binding of alpha melanocyte-stimulating hormone to its receptor; fat, which encodes carboxypeptidase E; tubby, which encodes a putative phosphodiesterase; obese, which encodes a circulating satiety protein; and diabetes, which encodes the receptor for the obese gene product. A more detailed understanding of the functional interrelationships of these genes should lead to important new insights into the causes and potential therapies for human obesity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8939064     DOI: 10.1002/bies.950181105

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  5 in total

1.  Intra- and interindividual variation in gene expression in human adipose tissue.

Authors:  Esther A van Beek; Arjen H Bakker; Philip M Kruyt; Marten H Hofker; Wim H Saris; Jaap Keijer
Journal:  Pflugers Arch       Date:  2006-10-24       Impact factor: 3.657

2.  Low and high fat diets inconsistently induce obesity in C57BL/6J mice and obesity compromises n-3 fatty acid status.

Authors:  Diana L Tallman; Amy D Noto; Carla G Taylor
Journal:  Lipids       Date:  2009-06-03       Impact factor: 1.880

3.  Oestradiol and diet modulate energy homeostasis and hypothalamic neurogenesis in the adult female mouse.

Authors:  E P Bless; T Reddy; K D Acharya; B S Beltz; M J Tetel
Journal:  J Neuroendocrinol       Date:  2014-11       Impact factor: 3.627

4.  Obesity and hyperleptinemia in metallothionein (-I and -II) null mice.

Authors:  J H Beattie; A M Wood; A M Newman; I Bremner; K H Choo; A E Michalska; J S Duncan; P Trayhurn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

5.  Analysis of beta3 adrenergic receptor gene polymorphism using noninvasive samples obtained at scheduled infant health checkups.

Authors:  M Tadokoro; C Sato; N Takeda; S Suna; F Asakawa; F Jitsunari
Journal:  Environ Health Prev Med       Date:  2000-01       Impact factor: 3.674

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.